Repligen's Research & Development rose 4598.35% to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.7 million, marking a year-over-year increase of 2613.38%. This contributed to the annual value of $43.2 million for FY2024, which is 111.89% up from last year.
Per Repligen's latest filing, its Research & Development stood at $14.2 million for Q3 2025, which was up 4598.35% from $14.0 million recorded in Q2 2025.
In the past 5 years, Repligen's Research & Development registered a high of $14.2 million during Q3 2025, and its lowest value of $7.6 million during Q1 2021.
For the 5-year period, Repligen's Research & Development averaged around $10.8 million, with its median value being $10.6 million (2024).
Its Research & Development has fluctuated over the past 5 years, first soared by 10701.04% in 2021, then tumbled by 819.7% in 2024.
Over the past 5 years, Repligen's Research & Development (Quarter) stood at $9.1 million in 2021, then grew by 21.87% to $11.1 million in 2022, then decreased by 7.45% to $10.3 million in 2023, then grew by 13.53% to $11.7 million in 2024, then grew by 21.39% to $14.2 million in 2025.
Its Research & Development stands at $14.2 million for Q3 2025, versus $14.0 million for Q2 2025 and $12.9 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value